Infliximab does not suppress the tuberculin skin test (purified protein derivative)


Hatemi G. , Melikoglu M. , Fresko I., Masatlioglu S., Tascilar K., Yazici H.

JOURNAL OF RHEUMATOLOGY, cilt.34, ss.474-480, 2007 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 34 Konu: 3
  • Basım Tarihi: 2007
  • Dergi Adı: JOURNAL OF RHEUMATOLOGY
  • Sayfa Sayıları: ss.474-480

Özet

Objective. Tuberculin skin testing with purified protein derivative (PPD) is part of tuberculosis (TB) screening in patients receiving infliximab. We assessed whether infliximab, a strong inhibitor of inflammation, suppressed dermal induration, the outcome of this test. We also reassessed the booster phenomenon and the interobserver variability in tuberculin testing.